Press Releases

High-Quality Dexmedetomidine Hydrochloride (API) Meeting CP & EP Standards

Inizio Biotech makes key leadership appointment to meet demand from emerging biotech

Clinion - Platinum Sponsor for ISCR 3rd Autumn Conference 2022

Clinion is anticipating the world’s leading clinical research specialists to participate in the ISCR 3rd Autumn Conference, with the purpose of stepping into a brand-new era of clinical trial innovation! HICC, Novotel, Hyderabad, Telangana, India, 17 September 2022.

Biological Stains for Laboratory and Diagnostic Use

Graphene Modification Helps to Unlock New Potentials

Accelerated Shelf-Life Testing to Assess Drug Stability

Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

BioIVT Acquires XenoTech, a Leading Provider of Products and Services for Preclinical Testing of New Drug Candidates

XenoTech specializes in providing ADME-Tox products and research services, in particular drug metabolism and pharmacokinetics (DMPK) and drug-drug interaction (DDI) studies.

Ayala Pharmaceuticals Presents Positive Interim Data from RINGSIDE Pivotal Phase 2/3 Trial of AL102 in Desmoid Tumors at ESMO Congress 2022

BOC Sciences August Promotion: Comprehensive Labeled Peptides with Stable Quality

As a pioneer in stable isotopic labeling chemistry, BOC Sciences develops a large variety of SIL compounds. Its promotion of labeled peptides, the increasingly used materials for convenient detection in research, is on the boil in August.

BOC Sciences Outlines Its Contribution of Peptides to Cardiovascular Research

BOC Sciences' monthly report released in August showed that its peptide products had vastly facilitated the R&D of cardiovascular therapies.

BOC Sciences August Promotion: Compound Docking Solutions for Drug Discovery

As the leading expert in computer-aided drug discovery, BOC Sciences has developed compound docking technologies to facilitate the discovery of novel ligands for over 30 targets.

BOC Sciences 2022 Free Webinar: Viral RNA Modifications and Implications for Novel Therapeutics

BioIVT Highlights ADME-Tox Research Advances at ISSX/MDO 2022

BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, is highlighting recent ADME-Tox research at the 13th International Meeting of the International Society for the Study of Xenobiotics (ISSX) and 24th International Symposium on Microsomes and Drug Oxidations (MDO). This conference will be held from September 11-14 at the Westin Seattle.

Introducing Freyr ARTWORK 360

Freyr has announced an exclusive artwork lifecycle management tool that will significantly emphasise end-to-end automation of creative and compliant artwork solutions and simplify the review process through a better graphic collaboration using a built-in annotation tool.

World Gynecologic Oncology Awareness Day (World GO Day): On September 20, 2022, turn the globe purple!

ESGO has announced a new challenge for World Gynecologic Oncology Awareness Day, to inspire and motivate women all around the world to improve their health by incorporating regular physical activity into their daily routine.

Trinity Health Partners with Orexo US to Expand Patient Access to Digital Therapeutics

Cytel expansion unlocks innovative clinical development expertise for APAC biopharma sector

Cytel Inc. has expanded its operations into the Asia-Pacific region (APAC).

“Genome Editing of Immune Cells” - New Lonza Virtual Event

Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery.

mdgroup Chief Operating Officer LaQuinta Jernigan Honoured as one of 100 Most Inspiring People in Life Sciences 2022

mdgroup Chief Operating Officer LaQuinta Jernigan Honoured as one of 100 Most Inspiring People in Life Sciences 2022 Recognized for championing diversity and collaboration within the clinical trials industry